Acute Kidney Injury clinical trials at UCSD
1 in progress, 0 open to new patients
Sorry, not currently recruiting here
Phase 2 multicenter study to be conducted in up to 50 qualified participating sites in the United States to assess the efficacy and safety of Reltecimod vs placebo in patients with abdominal sepsis-associated Stage 2/3 AKI.
San Diego, California and other locations